DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Colleoni M, Luo W, Karlsson P. et al.
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol 2018;
19: 127-138
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.